Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Inflammation: early-phase trial registry
51 of 133 indexed Inflammation trials are currently recruiting, with more weight in Phase 1-2.
Corpus placement: #86 of 28,707 conditions by registered trial count.
133 US clinical trials · 51 currently recruiting · #86 of 28,707 conditions by registered trial count
Inflammation: 133 US clinical trials tracked, 51 recruiting.
Inflammation is the subject of 133 registered US clinical trials on ClinicalTrials.gov, 51 of them currently open to new participants. 13 are in Phase 3-4 (later-stage) and 26 in Phase 1-2 (earlier-stage). The most active sponsor is Massachusetts General Hospital, running 6 of these trials.
Enrollment posture brief
Registry condition inflammation
OPEN 51 | RECR 38% | LATE 13 | EARLY 26 | RANK #86 | SPON 6
Volume-matched condition peers
Nearest open-share peer: Adolescent Behavior (38% recruiting · 47 trials)
Inflammation lists 51 open slots (38% of 133 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Inflammation on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Inflammation recruits in line with its size-band peers.
51 of 133 indexed trials (38.3%) are open to enrollment, against a 37.1% average across 139 conditions with 100+ trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
Sponsorship of Inflammation trials is spread across many organizations.
Massachusetts General Hospital accounts for 6 of 133 trials (4.5%). 95 distinct sponsors appear on at least one study for this condition label.
-
Most Inflammation trials plan to enrol fewer than 100 people.
Median target enrolment is 64 among the 133 trials that report a genuine target (sentinel values excluded). 85 of those (63.9%) plan for fewer than 100 participants.
-
Inflammation research is mostly interventional.
107 interventional and 26 observational studies make up this index (80.5% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
133 total, page 3 of 3
Bioequivalency Study of Meloxicam Tablets Under Fasting Conditions
Roxane Laboratories
NCT00618163
Effect of Diet on Vascular Disease in Pre-Menopausal Women
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
NCT00484861
Gut-level Antiinflammatory Activities of Green Tea in Metabolic Syndrome
Ohio State University
NCT03973996
Effect of Whole Blueberry Powder Consumption on Depression in a Central Louisiana Population
Louisiana State University, Baton Rouge
NCT04398784
The Effects of Antioxidants in Blueberry Powder on Inflammation Induced by a Single High Fat Meal.
USDA, Western Human Nutrition Research Center
NCT01594008
Oxytocin for Oxidative Stress and Inflammation
Florida Institute for Human and Machine Cognition
NCT04732247
Salmon Intake and Gut Health in Adults
University of Colorado, Denver
NCT04792216
Safety and Efficacy of Salsalate to Treat Endothelial Dysfunction in HIV-infected Adults
University Hospitals Cleveland Medical Center
NCT01046682
Flow-Restorative Yoga to Decrease Pain and Inflammation
Cornell University
NCT03790098
Acute Effects of TCIG vs ECIG in PLWH
University of California, Los Angeles
NCT04568395
Dairy Fat and Fermentation Study
Tufts University
NCT05840081
Zinc Supplement Before or With Food in Generally Healthy Men
UCSF Benioff Children's Hospital Oakland
NCT03619421
Beef Burger Versus a Vegetarian Burger
Loma Linda University
NCT04034160
PET/CT Imaging Companion Study To ACTG A5314
Massachusetts General Hospital
NCT02312219
Protein and Recovery From Exercise-induced Muscle Damage
Appalachian State University
NCT02034721
Effect of Statin Therapy on C-reactive Protein Levels in Patients With Chronic Obstructive Lung Disease (COPD)
VA Loma Linda Health Care System
NCT00655993
Effect of Fasting and Refeeding on T-cell Fate
National Heart, Lung, and Blood Institute (NHLBI)
NCT02719899
Effects of Etravirine on Endothelial Function in HIV-uninfected Adults: A Pilot Study
Indiana University
NCT00871234
Effect of Fermented Soy Based Product on Cardiometabolic Risk Factors
Loma Linda University
NCT03429920
Open Multi-centre Investigation to Evaluate Signs and Symptoms of Local Inflammation/Infection on Chronic Ulcers and Partial Thickness Burns When Using Mepilex Border Ag as an Anti-microbial Wound Dressing
Molnlycke Health Care AB
NCT01214811
A Study of Tomato Products and Disease Risk
Clinical Nutrition Research Center, Illinois Institute of Technology
NCT00966550
Impact of Ascorbic Acid on Post-Cardiothoracic Surgery Inflammation
Hartford Hospital
NCT00519337
Banana Cultivars and Exercise Performance and Recovery
Appalachian State University
NCT02994628
The Effects Grapes on Health Indices
University of California, Davis
NCT01674231
Glucosamine and Chondroitin Effects
Fred Hutchinson Cancer Center
NCT01682694
Effects of Adding Raisins to the American Diet on Fecal Microbiota Composition
University of Florida
NCT02713165
Effects of Adding Chickpeas to the American Diet (Long Term Study)
University of Florida
NCT02375373
Inflammation and Protein Restriction
University of Florida
NCT03995979
Circadian Rhythm Disruption Effects on Smoke Inhalation
University of Montana
NCT04955431
The Biodistribution of 1-[2 Deoxy-2, -18 Fluroarabinfuranosyl]Cytosine [18FAC] in Healthy Subjects and Patients With Cancer, Autoimmune/Inflammatory Diseases
Jonsson Comprehensive Cancer Center
NCT01180907
Flaxseed Modulates Inflammation and Oxidative Stress in CF
University of Pennsylvania
NCT02014181
Efficacy of Ketorolac 0.4% in Prostaglandin Suppression
Allergan
NCT00791323
hsCRP Clinical Inflammation Marker for Human Bisphenol A Food Contamination
Center for Research on Environmental Chemicals in Humans
NCT04600765
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 10 |
| Phase 2 | 16 |
| Phase 3 | 8 |
| Phase 4 | 5 |
Top Sponsors
Named interventions
Most-linked intervention names on Inflammation records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Inflammation trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Inflammation page
133 registered trials, 51 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 51 Inflammation trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- Massachusetts General Hospital sponsors the most Inflammation trials on record, review their full trial history before evaluating a specific study. See Massachusetts General Hospital's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Inflammation condition card totals 133 registered trials; most-linked intervention Placebo; top US site state California. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.